RICHARD VOWLES: Open Payments
NPI 1619631124 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,638 in 91 payments from 12 companies in 2025. Trend: 2023 $1,591 · 2024 $1,363 · 2025 $4,638
Food & beverage: $2,323Consulting: $1,600Travel & lodging: $715
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $3,068 |
| Teva Pharmaceuticals USA, Inc. | 15 | $337 |
| Axsome Therapeutics, Inc. | 7 | $316 |
| ABBVIE INC. | 14 | $248 |
| Alkermes, Inc. | 8 | $184 |
| Vanda Pharmaceuticals Inc. | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
Products named: CAPLYTA, Auvelity, AUSTEDO XR, VRAYLAR, ARISTADA, FANAPT, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
